1. Home
  2. MNR vs WGS Comparison

MNR vs WGS Comparison

Compare MNR & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mach Natural Resources LP

MNR

Mach Natural Resources LP

HOLD

Current Price

$10.85

Market Cap

2.3B

Sector

N/A

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$66.54

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNR
WGS
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
MNR
WGS
Price
$10.85
$66.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
8
Target Price
$16.63
★ $93.50
AVG Volume (30 Days)
519.0K
★ 710.8K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 18.26%
N/A
EPS Growth
N/A
★ 62.37
EPS
★ 0.38
N/A
Revenue
★ $1,175,390,000.00
$427,539,000.00
Revenue This Year
$37.31
$12.70
Revenue Next Year
N/A
$24.31
P/E Ratio
$28.61
★ N/A
Revenue Growth
21.22
★ 39.97
52 Week Low
$10.15
$32.21
52 Week High
$15.02
$170.87

Technical Indicators

Market Signals
Indicator
MNR
WGS
Relative Strength Index (RSI) 44.79 36.97
Support Level $10.77 $56.36
Resistance Level $13.82 $73.21
Average True Range (ATR) 0.21 4.58
MACD 0.12 -0.82
Stochastic Oscillator 72.04 15.85

Price Performance

Historical Comparison
MNR
WGS

About MNR Mach Natural Resources LP

Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas; the San Juan Basin region of New Mexico and Colorado; and the Permian Basin region of West Texas. The company is organized and managed as a single reportable segment, which is the exploration and production of oil, natural gas and NGLs (E&P Segment).

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: